Future of bioartificial liver support.

Many different artificial liver support systems (biological and non-biological) have been developed, tested pre-clinically and some have been applied in clinical trials. Based on theoretical considerations a biological artificial liver (BAL) should be preferred above the non-biological ones. However, clinical application of the BAL is still experimental. Here we try to analyze which hurdles have to be taken before the BAL will become standard equipment in the intensive care unit for patients with acute liver failure or acute deterioration of chronic liver disease.

• Publication year

  2009

• Venue

  World Journal of Gastrointestinal Surgery

• Publication date

  2009-11-30

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.4240/wjgs.v1.i1.21PMID 21160791PMCID PMC2999112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation.

  2009cited by this paper
• Non-toxicity of IV Injected Perfluorocarbon Oxygen Carrier in an Animal Model of Liver Regeneration Following Surgical Injury

  2009cited by this paper
• Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance

  2009cited by this paper
• Liver support devices

  2008cited by this paper
• Hepatic reconstruction from fetal porcine liver cells using a radial flow bioreactor.

  2008cited by this paper
• Engineered Liver-Like Tissue on a Capillarized Matrix for Applied Research

  2007cited by this paper
• Acute liver failure: liver support therapies

  2007cited by this paper
• Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory

  2007cited by this paper
• Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy.

  2007cited by this paper
• Liver support systems.

  2007cited by this paper
• Acute liver failure: Summary of a workshop

  2007cited by this paper
• Liver support technology – an update

  2006cited by this paper
• Present and Future Developments in Hepatic Tissue Engineering for Liver Support Systems

  2006cited by this paper
• Significant survival prolongation in pigs with fulminant hepatic failure treated with a novel microgravity-based bioartificial liver.

  2006cited by this paper
• Hepatocyte transplantation: State of the art.

  2006cited by this paper
• Comparison between bioartificial and artificial liver for the treatment of acute liver failure in pigs.

  2006cited by this paper
• Personal view: current role of artificial liver support devices

  2006cited by this paper
• The Significant Improvement of Survival Times and Pathological Parameters by Bioartificial Liver with Recombinant HepG2 in Porcine Liver Failure Model

  2006cited by this paper
• Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system.

  2006cited by this paper
• Which Are the Right Cells to be Used in a Bioartificial Liver?

  2005cited by this paper
• Bioartificial liver systems: current status and future perspective.

  2005cited by this paper
• Effects of serum from patients with acute liver failure due to paracetamol overdose on human hepatocytes in vitro.

  2005cited by this paper
• Liver support systems: Promise and reality

  2005cited by this paper
• Hepatic tissue engineering for adjunct and temporary liver support: Critical technologies

  2004cited by this paper
• Clinical Application of Bioartificial Liver Support Systems

  2004cited by this paper
• Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a β1‐integrin pathway

  2004cited by this paper
• Hepatic tissue engineering for adjunct and temporary liver support: critical technologies.

  2004cited by this paper
• Serologic Analysis of Anti‐Porcine Endogenous Retroviruses Immune Responses in Humans After Ex Vivo Transgenic Pig Liver Perfusion

  2003cited by this paper
• Hepatocyte hollow‐fibre bioreactors: design, set‐up, validation and applications

  2003cited by this paper
• Extracorporeal liver support based on primary human liver cells and albumin dialysis--treatment of a patient with primary graft non-function.

  2003cited by this paper
• Combined Effect of Oxygen and Ammonia on the Kinetics of Ammonia Elimination and Oxygen Consumption of Adherent Rat Liver Cells

  2002cited by this paper
• Follow‐up by one‐ and two‐dimensional NMR of plasma from pigs with ischemia‐induced acute liver failure treated with a bioartificial liver

  2002cited by this paper
• A Bioartificial Liver--State of the Art

  2002cited by this paper
• Biologic Liver Support: Optimal Cell Source and Mass

  2002cited by this paper
• Treatment of Acute Liver Failure in Pigs Reduces Hepatocyte Function in a Bioartificial Liver Support System

  2002cited by this paper
• ASSESSMENT OF THE AMC-BIOARTIFICIAL LIVER IN THE ANHEPATIC PIG1

  2002cited by this paper
• Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure.

  2001cited by this paper
• Acute liver failure serum reduces hepatocyte-matrix adhesion by a cell death-independent mechanism

  2001cited by this paper
• Current Status of Xenotransplantation - A Review

  2001cited by this paper
• What progress with artificial livers?

  2001cited by this paper
• UvA-DARE ( Digital Academic Repository ) In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates

  2001cited by this paper
• Advances in bioartificial liver devices

  2001cited by this paper
• Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure.

  2000cited by this paper
• Successful ex vivo liver perfusion system for hepatic failure pending liver regeneration or liver transplantation.

  1999cited by this paper
• Assay to Detect Inhibitory Substances in Serum of Patients with Acute Liver Failure

  1999cited by this paper
• Significantly Improved Survival Time in Pigs with Complete Liver Ischemia Treated with a Novel Bioartificial Liver

  1999cited by this paper
• Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability.

  1999cited by this paper
• Transplantation intrapéritonéale d'hépatocytes isolés de porc: le foie bioartificiel implantable

  1998cited by this paper
• [Intraperitoneal transplantation of isolated hepatocytes of the pig: the implantable bioartificial liver].

  1998cited by this paper
• No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys.

  1998cited by this paper
• Experimental evaluation of a hybrid liver support system.

  1997cited by this paper
• Preclinical trial of a bioartificial liver support system in a porcine fulminant hepatic failure model.

  1996cited by this paper
• Inhibitors of hepatic DNA synthesis in fulminant hepatic failure

  1991cited by this paper

• Biocompatibility of the oxygen carrier polymerized human hemoglobin towards HepG2/C3A cells

  2023cites this paper
• Toward better drug development: Three-dimensional bioprinting in toxicological research

  2023cites this paper
• Novel Cell-Based Therapies in Hepatic Disorders

  2020cites this paper
• Hepatic tissue engineering

  2020cites this paper
• High-Throughput Identification of Molecular Factors that Promote Phenotypic Stabilization of Primary Human Hepatocytes in vitro

  2016cites this paper
• Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study

  2016cites this paper
• Influence of 3D porous galactose containing PVA/gelatin hydrogel scaffolds on three-dimensional spheroidal morphology of hepatocytes

  2015cites this paper
• Gelatin functionalizations for cell embedding in 3D geometries using rapid prototyping technology

  2015cites this paper
• Chapter 46 – Hepatic Tissue Engineering

  2014cites this paper
• The Artificial Liver, in vivo Tissue Engineering, and Organ Printing

  2014cites this paper
• Galactose-functionalized gelatin hydrogels improve the functionality of encapsulated HepG2 cells.

  2014cites this paper
• Liver tissue engineering

  2014cites this paper
• Human hepatic cell behavior on polysulfone membrane with double porosity level

  2013cites this paper
• Rapid and Scalable Human Stem Cell Differentiation: Now in 3D

  2013cites this paper
• Study of porcine hepatocyte-entrapped bioartificial liver in surgery-induced fulminant hepatic failure rabbits

  2013cites this paper
• Stem cell differentiation and human liver disease.

  2012cites this paper
• Bioengineering methods for analysis of cells in vitro.

  2012cites this paper
• Key challenges to the development of extracorporeal bioartificial liver support systems.

  2012cites this paper
• Progress of key strategies in development of electrospun scaffolds: bone tissue

  2012cites this paper
• Liver Tissue Engineering

  2011cites this paper
• Acute-on-chronic liver failure: extracorporeal liver assist devices

  2011cites this paper
• Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attrition.

  2011cites this paper
• Acute liver failure

  2011cites this paper
• Cell-based therapeutics for liver disorders.

  2011cites this paper